Now if all plays out we have potential for the following;
Phase 3 start SITC abstract announcement. EU approval - certainly possible as per presentation, IND filing for NEO. SITC - presentation for combo results Canine vaccine approval.
All above could and I believe will occur over the next 3 1/2 months.
If all plays out as I believe most will and results will be positive, share price will be way above where it is now, and probably reason why Fidelity wanted in after Amgen deal.